| Oligohydramnios (low amniotic fluid) has been linked to a slew of problems, including mispresentations,
umbilical cord compression, and meconium aspiration syndrome, all of which result in a higher rate of surgical delivery.
The crux of therapy is keeping the mother hydrated and supplementing her with antioxidants and vital amino acids. There
are many treatment options for oligohydramnios and oligohydramnios consequences. Objective: To assess the effectiveness
of L-Arginine sachets vs EAA infusions for the treatment of oligohydramnios patients. Study Design: Comparative
prospective research. Materials and Methods: Our research comprised 100 women diagnosed with oligohydramnios who
visited a prenatal clinic. Only L-Arginine sachets were given to 50 patients (5 gm twice a day). Another 50 people had
complete EAA infusions (200 ml on alternate day preceded by 500 ml of 10 percent fructodex). The results of both groups
were calculated using the following criteria: mean rise in liquor, treatment supply interval, and neonatal survival. Results:
The study and control groups were 32.3 and 31.6 weeks pregnant at the time of enrollment, respectively. In both groups,
the mean AFI at the time of enrollment was 6.13 0.53, 6.10 0.31. Patients were born at a gestational age of 37 weeks (in
study group 80 percent in control group 78 percent). The mean AFI at the conclusion of the treatment intervention was
(8.63 0.71 in the study group and 8.53 0.70 in the control group, respectively), indicating a 2.50 0.18 improvement in the
study group and 2.43 0.39 in the control group. These patients had no severe neonatal morbidity. In both groups, there was
a significant increase in liquor volume. Conclusion: Treatments with L-Arginine and All EAA infusion led in a
considerable increase in liquor and a longer pregnancy length. However, L-Arginine sachets are less expensive and do not
need hospitalisation. There is also no substantial difference between the study and control groups' outcomesddd |
